LianBio Announces Results from Phase 3 EXPLORER-CN Trial of

EXPLORER-CN data presented in oral late-breaking science session at ESC 2023Data from the trial published simultaneously in JAMA CardiologyMavacamten demonstrated improvement in Valsalva LVOT peak gradient, LVOT obstruction, clinical symptoms,

Related Keywords

China , Shanghai , Peking , Beijing , Chinese , Elizabeth Anderson , Katherine Smith , Josh Xu , International Medical Department , Exchange Commission , Vp Communications , Union Medical College Hospital , European Society Of Cardiology , York Heart Association , European Society , New York Heart Association , Zhuang Tian , Deputy Director , Peking Union Medical College Hospital , Annual Report , Region ,